Abstract
Hypoglycaemic pharmaceuticals are recently more and more frequently detected in the environment. In our previous study, we have shown that even though many of them undergo significant primary degradation some are transformed to stable products or undergo such transformation that a large part of the structure is still preserved. One of the main routes of elimination from wastewaters or surface waters is biodegradation and a lack thereof leads to accumulation in the environment. Within this work we tested the ultimate biodegradability of six oral antidiabetics: metformin and its main metabolite guanylurea, acarbose, glibenclamide, gliclazide, glimepiride and repaglinide. We also compared the experimental results obtained in this and accompanying work with models designed to predict biodegradability and showed that these models are only moderately successful. Additionally, we examined these compounds in acute Daphnia magna test to check if they might pose an ecotoxicological threat. Combining the results of biodegradability and toxicity tests allows a preliminary assessment of their potential environmental impact.
Citations
-
3 8
CrossRef
-
0
Web of Science
-
4 0
Scopus
Authors (6)
Cite as
Full text
- Publication version
- Accepted or Published Version
- License
- open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuł w czasopiśmie wyróżnionym w JCR
- Published in:
-
JOURNAL OF HAZARDOUS MATERIALS
no. 333,
pages 154 - 161,
ISSN: 0304-3894 - Language:
- English
- Publication year:
- 2017
- Bibliographic description:
- Markiewicz M., Jungnickel C., Stolte S., Białk-Bielińska A., Kumirska J., Mrozik W.: Ultimate biodegradability and ecotoxicity of orally administered antidiabetic drugs// JOURNAL OF HAZARDOUS MATERIALS. -Vol. 333, (2017), s.154-161
- DOI:
- Digital Object Identifier (open in new tab) 10.1016/j.jhazmat.2017.03.030
- Bibliography: test
-
- M. Markiewicz, C. Jungnickel, S. Stolte, A. Białk-Bielińska, J. Kumirska, W. Mrozik, Primary degradation of antidiabetic drugs, J. Hazard. Mater. 324B (2017) 428-435, http://dx.doi.org/10.1016/j.jhazmat.2016.11.008. open in new tab
- P. Boucher, D. Ditlecadet, C. Dubé, F. Dufresne, Unusual duplication of the insulin-like receptor in the crustacean Daphnia pulex, BMC Evol. Biol. 10 (2010) 305, http://dx.doi.org/10.1186/1471-2148-10-305. open in new tab
- C. Hampp, V. Borders-Hemphill, D.G. Moeny, Diane K Wysowski, Use of antidiabetic drugs in the U.S., 2003-2012, Diabetes Care 37 (2014). open in new tab
- J.F. Contrera, E.J. Matthews, N.L. Kruhlak, R.D. Benz, Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose, Regul. Toxicol. Pharmacol. 40 (2004) 185-206, http://dx.doi.org/10.1016/j.yrtph. 2004.08.004. open in new tab
- US Food and Drug Administration, Maximum Recommended Therapeutic Dose (MRTD) Database, (2014). open in new tab
- A.J. Krentz, C.J. Bailey, Oral antidiabetic agents current role in type 2 diabetes mellitus, Drugs 65 (2005) 385-411. open in new tab
- S.K. Khetan, T.J. Collins, Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry, Chem. Rev. 107 (2007) 2319-2364, http://dx. doi.org/10.1021/cr020441w. open in new tab
- A. Schuster, C. Hädrich, K. Kümmerer, Flows of active pharmaceutical ingredients originating from health care practices on a local regional, and nationwide level in Germany-is hospital effluent treatment an effective approach for risk reduction? Water Air Soil Pollut. 8 (2008) 457-471. open in new tab
- C. Trautwein, K. Kümmerer, Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea, Chemosphere 85 (2011) 765-773. open in new tab
- O.A.H. Jones, N. Voulvoulis, J.N. Lester, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res. 36 (2002) 5013-5022. open in new tab
- A.L.N. van Nuijs, I. Tarcomnicu, W. Simons, L. Bervoets, R. Blust, P.G. Jorens, et al., Optimization and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater, Anal. Bioanal. Chem. 398 (2010) 2211-2222. open in new tab
- M. Scheurer, F. Sacher, H.-J. Brauch, Occurrence of the antidiabetic drug metformin in sewage and surfacewaters in Germany, J. Environ. Monit. 11 (2009) 1608-1613. open in new tab
- C. Trautwein, J.-D. Berset, H. Wolschke, K. Kümmerer, Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle, Environ. Int. 70 (2014) 203-212, http://dx.doi.org/10.1016/j.envint.2014.05.008. open in new tab
- M. Oosterhuis, F. Sacher, T.L. Ter Laak, Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data, Sci. Total Environ. 442 (2013) 380-388, http://dx.doi.org/10.1016/j.scitotenv.2012.10.046. open in new tab
- M. Cleuvers, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol. Lett. 142 (2003) 185-194, http://dx.doi.org/ 10.1016/S0378-4274(03)00068-7. open in new tab
- V.L. Cunningham, M. Buzby, T. Hutchinson, F. Mastrocco, N. Parke, N. Roden, Effects of human pharmaceuticals on aquatic life: next steps, Environ. Sci. Technol. 40 (2006) 3456-3462, http://dx.doi.org/10.1021/es063017b. open in new tab
- W. Mrozik, J. Stefańska, Adsorption and biodegradation of antidiabetic pharmaceuticals in soils, Chemosphere 95 (2014) 281-288, http://dx.doi.org/ 10.1016/j.chemosphere.2013.09.012. open in new tab
- OECD, Guideline for testing of chemicals 301 − Ready Biodegradability, 1992. open in new tab
- US EPA Estimation Programs Interface Suite TM for Microsoft ® Windows EPI Suite TM v 4.1, US EPA. Estimation Programs Interface Suite TM for Microsoft ® Windows, EPI Suite TM v 4.1., (2014). open in new tab
- U.F. Wehmeier, W. Piepersberg, Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose, Appl. Microbiol. Biotechnol. 63 (2004) 613-625, http://dx.doi.org/10.1007/s00253-003-1477-2. open in new tab
- J. Radjenovic, S. Pérez, M. Petrovic, D. Barceló, Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybridquadrupole time-of-flight and quadrupole ion trap mass spectrometry, J. Chromatogr. A. 1210 (2008) 142-153. open in new tab
- F. Ingerslev, B. Halling-Sørensen, Biodegradability properties of sulfonamides in activated sludge, Environ. Toxicol. Chem. 19 (2000) 2467-2473. open in new tab
- R.S. Boethling, E. Sommer, D. DiFiore, Designing small molecules for biodegradability, Chem. Rev. 107 (2007) 2167-2820. open in new tab
- A. Gallego, M.S. Fortunato, J. Foglia, S. Rossi, V. Gemini, L. Gomez, et al., Biodegradation and detoxification of phenolic compounds by pure and mixed indigenous cultures in aerobic reactors, Int. Biodeterior. Biodegrad. 52 (2003) 261-267, http://dx.doi.org/10.1016/j.ibiod.2003.07.001. open in new tab
- L. Alvarez-Cohen, Gerald E. Speitel Jr., Kinetics of aerobic cometabolism of chlorinated solvents, Biodegradation 12 (2001) 105-126, http://dx.doi.org/10. 1023/A:1012075322466. open in new tab
- H. Sanderson, M. Thomsen, Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicit, Toxicol. Lett. 187 (2009) 84-93, http://dx.doi.org/10.1016/j.toxlet.2009.02.003. open in new tab
- Verified by:
- Gdańsk University of Technology
seen 101 times
Recommended for you
Modeling of pharmaceuticals mixtures toxicity with deviation ratio and best-fit functions models
- M. Wieczerzak,
- B. Kudłak,
- G. Yotova
- + 4 authors